Jeffrey Zweegers

‘Happy’ drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the Bio<scp>CAPTURE</scp>network

J. M. P. A. van den Reek, Jeffrey Zweegers, Wietske Kievit et al. · British Journal of Dermatology · 2014 · 97 citations

Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions

Denise Josephina Johanna Hermans, C.G. Bauland, Jeffrey Zweegers et al. · British Journal of Dermatology · 2012 · 91 citations

Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-t

Jeffrey Zweegers, J.M.P.A. van den Reek, P.C.M. van de Kerkhof et al. · British Journal of Dermatology · 2016 · 78 citations

Summary of the Dutch S3-Guidelines on the treatment of psoriasis 2011

Jeffrey Zweegers, E.M.G.J. de Jong, Tamar Nijsten et al. · Dermatology Online Journal · 2014 · 55 citations · Full text

Comparison of the 1- and 5-year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTURE registry

Jeffrey Zweegers, J.M.M. Groenewoud, J. M. P. A. van den Reek et al. · British Journal of Dermatology · 2016 · 53 citations